Company Number: 13041271

Analysis Date: 2025-07-20 12:52 UTC

1. Risk Rating: LOW
   The company demonstrates a strong improvement in net assets and current assets over the last two years, supported by a significant increase in debtors owed by group undertakings. It has no overdue filings and maintains compliance with Companies House deadlines. The going concern assumption is supported by a letter of financial support from the parent company.

2. Key Concerns:

• High Debtors Concentration: The majority of current assets (approx. £9.14m) are debtors owed by group companies, indicating potential concentration risk and dependency on intercompany receivables for liquidity.
• Relatively Low Cash Reserves: Despite large current assets, cash at bank is modest (£546k), which may constrain liquidity to meet immediate obligations without collection of receivables.
• Creditors After One Year: The company reports long-term creditors of £397k, indicating some longer-term liabilities that require monitoring for repayment capacity.

3. Positive Indicators:

• Improved Net Assets and Equity: Net assets increased from £113k in 2022 to £878k in 2023, reflecting profitability and retained earnings of £765k in 2023.
• No Filing or Compliance Issues: Accounts and confirmation statements are filed on time with no overdue returns, demonstrating regulatory compliance and good governance.
• Parent Company Support: The directors have confirmed a letter of financial support from BioNTech SE, mitigating going concern risk and providing assurance of continued financial backing.

4. Due Diligence Notes:

• Review the aging and collectability of intercompany debtors, including terms of repayment and any history of delays or disputes.
• Assess the nature and terms of the long-term creditors to understand obligations and potential refinancing or repayment risks.
• Investigate the relationship and financial health of the parent and group companies to gauge the reliability of their support and receivables.
• Confirm the accuracy of the restatement adjustments referenced in the accounts and their impact on prior year comparatives.
• Evaluate the company’s dependency on intra-group transactions for revenue, assessing operational sustainability outside of the group context.